A revista einstein (São Paulo) - e-ISSN 2317-6385 é dedicada à divulgação de conteúdo científico de alta qualidade para o avanço da nossa compreensão das doenças humanas e com o objetivo de melhorar a prevenção, o cuidado, o diagnóstico e o tratamento de pacientes em todo o mundo.
Research indicates that in the beginning of the COVID-19 pandemic there was a decrease in number of tuberculosis diagnosis. This reduction has been suggested to have occurred due to social distancing and more constant hygiene routines, such as hand washing and sanitizing, as well as continued use of masks.(,)
[…]
The rise of tuberculosis: regression in combating advances as a legacy of COVID-19?
BarrosGM. The rise of tuberculosis: regression in combating advances as a legacy of COVID-19?. einstein (Sao Paulo). 2022;20:eCE0196. https://doi.org/10.31744/einstein_journal/2022CE0196
Barros,Gabriel Martins de. The rise of tuberculosis: regression in combating advances as a legacy of COVID-19?. einstein (Sao Paulo)., v. 20, eCE0196, nov. 2022. https://doi.org/10.31744/einstein_journal/2022CE0196
Barros,G.M. (2022). The rise of tuberculosis: regression in combating advances as a legacy of COVID-19?. einstein (Sao Paulo).,20, eCE0196. https://doi.org/10.31744/einstein_journal/2022CE0196
Barros,Gabriel Martins de. The rise of tuberculosis: regression in combating advances as a legacy of COVID-19?. einstein (Sao Paulo). [online]. 2022, vol. 20, [cited 2025-09-06], eCE0196. Available from: <https://journal.einstein.br/pt-br/article/the-rise-of-tuberculosis-regression-in-combating-advances-as-a-legacy-of-covid-19/>. ISSN 1679-4508. https://doi.org/10.31744/einstein_journal/2022CE0196
Figure 5
Risk of bias assessment of non-RCTs using the ROBINS-I tool
Non-RCT, nonrandomized controlled trial; ROBINS-I, Risk of Bias in Non-Randomized Studies-of Interventions